GF/B51/EDP14
Approved by the Board on: 19 November 2024
Decision on the Secretariat’s Recommendation on Funding from the 2023-2025 Allocation
The Board:
- Approves the funding recommended for each country disease component, and its constituent grants, as listed in Table 1 and Table 2 of GF/B51/ER10 (“Table 1” and “Table 2”);
- Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1 and Table 2, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;
- Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shall be committed in annual tranches; and
- Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.
Budgetary Implications
This decision does not have material budgetary implications for operating expenses.